NEX2US Newsletter Issue 08 | January 2022
Industry member
Cell, Tissue and Gene Therapy Products
Chinese Proprietary Medicines
Controlled drugs
Cosmetic products
Health supplements
Homeopathic medicines
Medical devices
Psychotropic substances and poisons
Therapeutic Products
Traditional medicines
27 January 2022
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Topics
Awards and Recognition
HSA won two awards at the Pro-Enterprise Panel - Singapore Business Federation (PEP-SBF) Awards 2021
Regulatory Updates and Process Enhancements
Facilitate Therapeutic Products (TP) registration and post-approval variation
Finalised guidance on e-labelling of TP
New regulations for Cell, Tissue and Gene Therapy Products (CTGTP)
Refined Medical Devices (MD) Product Classification Guide
Enhanced Medical Device Information and Communication System (MEDICS) to capture Unique Device Identification (UDI) data
Finalised guidelines for 3D-printed MD
MD Grouping Tool
International and Bilateral Collaborations
Access Consortium
Project Orbis
Singapore's HSA and Republic of Korea's (ROK) Ministry of Food and Drug Safety (MFDS) established mutual confidence in the Good Manufacturing Inspections of Pharmaceutical Products
International Medical Device Regulators Forum (IMDRF) Medical Device Single Audit Programme (MDSAP)
HSA registered medical devices are now eligible for expedited registration pathways in more ASEAN markets
News and Engagements
Regulatory Fee Revision for Health Products
Complementary Health Products (CHP) Industry Training Workshop Series 2021
2021 WHO-UMC-HSA Inter-Regional Pharmacovigilance Training Workshop: Enhancing Preparedness for Pharmacovigilance
Webinar: ISO13485 Certification for Medical Device (MD) Licensed Dealers
Click on the link below to download the issue in pdf:
Subscribe to stay up to date with HSA news and regulatory updates.
